Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014823 |
| CAS No | NA |
| Mol.F. | C17H21N11O7 |
| Mol.Wt. | 491.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014824 |
| CAS No | NA |
| Mol.F. | C11H12BrN3O |
| Mol.Wt. | 272.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014825 |
| CAS No | NA |
| Mol.F. | C26H26N2O3 |
| Mol.Wt. | 414.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014826 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S |
| Mol.Wt. | 336.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014827 |
| CAS No | NA |
| Mol.F. | C23H30N2O4 |
| Mol.Wt. | 398.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014828 |
| CAS No | NA |
| Mol.F. | C19H24N2O3 |
| Mol.Wt. | 328.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014829 |
| CAS No | NA |
| Mol.F. | C26H28N2O3 |
| Mol.Wt. | 416.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014830 |
| CAS No | NA |
| Mol.F. | C26H30N2O2 |
| Mol.Wt. | 402.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014831 |
| CAS No | NA |
| Mol.F. | C26H28N2O3 |
| Mol.Wt. | 416.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014832 |
| CAS No | NA |
| Mol.F. | C7H6ClN5O3 |
| Mol.Wt. | 243.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014833 |
| CAS No | NA |
| Mol.F. | C14H20N4O3S |
| Mol.Wt. | 324.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014834 |
| CAS No | NA |
| Mol.F. | C14H19N5O4S |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014835 |
| CAS No | NA |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014836 |
| CAS No | NA |
| Mol.F. | C27H36N6O3S |
| Mol.Wt. | 524.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014837 |
| CAS No | 75051-59-1 |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014838 |
| CAS No | NA |
| Mol.F. | C14H20N4O4S |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |